The Circadian Skin: Chronobiology as a New Frontier in Dermatological Therapy

• by Diala Haykal

• September 7, 2026

FDA Approves Melanoma BRAF Companion Test

The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.

• by Kathryn Wighton

• August 10, 2026

• 1 min

Longitudinal Performance of the Psoriasis Epidemiology Screening Tool (PEST) in Canada and Latin America: Results from the Prospective, Observational, 5-Year PURE Registry

• by Jennifer Beecker, Lorne Albrecht, Ignacio Dei-Cas, Melinda Gooderham, Charles Lynde, Kim A. Papp, Paul Keown, Antonio Vieira, Mahmoud S. Farag, Marie Maguin, Tanya Zappitelli, Philip S. Helliwell

• July 21, 2026

Understanding Social Drivers of Health Among US Adults with Psoriasis from Different Races and Ethnicities

• by Victoria Barbosa, Tina Bhutani-Jacques, Valerie D. Callender, Elizabeth D. Bacci, Evangeline Pierce, Beth Mitchell, Julia R. Correll, Nicole Huang

• July 15, 2026